JPRN-UMIN000003982Completed未知
Randomized control trial of increased dose therapy with Entecavir vursus combination therapy with Entecavir and Adefovir in CHB patients with inadequate nucleoside analogue therapy - Compare the value of increased dose to combination therapy with nucleoside analogues
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Hyogo College Of Medicine
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 37years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Resistant to Entecavir 2. Intolerance to Entecavir 3. Pregnant, lactating women 4. Possibly pregnant women 5. Chronic kidney failure 6. Creatinine clearance of <=50 mL/ min 7. Severe heart diseases 8. Decompensated liver cirrhosis 9. Liver transplant patient 10. HIV/HBV superinfection
Investigators
Similar Trials
Completed
Not Applicable
A randomised controlled dose intensification clinical trial of chemotherapy with or without recombinant human granulocyte colony stimulating factor (G-CSF) in small cell lung cancer (SCLC)ung cancerSmall cell lung cancer (SCLC)CancerISRCTN15921116Medical Research Council (MRC) (UK)400
Active, not recruiting
Not Applicable
Randomized continuation, dose escalation trial of Sorafenib in pts with advanced HCC with radiological progression on prior sorafenib treatment (Phase II study) - ONC-2006-004MedDRA version: 9.1Level: LLTClassification code 10019695Term: Hepatic neoplasmHepatocellular carcinomaEUCTR2007-000758-30-ITISTITUTO CLINICO HUMANITAS
Completed
Phase 2
A study on Siddha Herboââ?¬â??Mineral Medicine Naaga chendooramfor the Diabetes Neurological complication(Madhumega Avathaigal)CTRI/2021/07/035067ational Institute of Siddha80
Recruiting
Phase 3
A Randomized Controlled Trial on Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapypancreatic cancerpancreatic ductal adenocarcinoma10027656NL-OMON55290niversitair Medisch Centrum Utrecht120
Not yet recruiting
Not Applicable
Dose escalation study for inoperable esophageal cancer patients.inoperable oesophageal tumorsdefinitive chemoradiationdose escalationNL-OMON25587dept of Radiotherapy, AMC, AmsterdamArhems Radiotherapeutisch Institute, Arnhemdept of oncology, Erasmusmc, Rotterdam260